Genexine, Top Search Ranking... Stock Price -1.38%
Genexine ranked among the top searched stocks for 13 days in the past month.
As of 9:30 AM on the 2nd, Genexine is trading at 179,000 KRW, down 1.38% from the previous day. This represents a 51.69% increase compared to August 12. Genexine is known as a company specializing in the development of biopharmaceuticals.
Over the past five days, individual investors have net purchased 326,729 shares, while foreigners and institutions have net purchased 20,152 shares and net sold 143,687 shares, respectively.
On August 31, Genexine became a market issue with the news of "FDA approval for Kimria combination therapy clinical Phase 1b," leading to a rise in its stock price.
Hot Picks Today
"Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- "Striking Will Lead to Regret": Hyundai-Kia Employees Speak Out... Uneasy Stares Toward Samsung Union
- Man in His 50s Arrested for Confining Girlfriend in Car After She Announced Breakup
- Assaulted by Elementary Student During Class... No Protection Due to 'Instructor' Status
- "If You Booked This Month, You Almost Lost Out... Why You Should Wait Until 'This Day' Before Paying for Flight Tickets"
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
